Using computer methods to understand how transcription control affects cancer development
Computational Approaches for Studying Transcription Elongation Control in Cancer
This study is looking at how certain genes behave in acute lymphoblastic leukemia to understand how they might lead to cancer, with the hope that this knowledge will help researchers find better treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10916365 on NIH RePORTER |
What this research studies
This research focuses on the role of transcription elongation in cancer, particularly in acute lymphoblastic leukemia. It employs advanced bioinformatics techniques to analyze genetic data and identify how misregulation of transcription factors contributes to cancer. By integrating machine learning and next-generation sequencing data, the project aims to provide insights that can help researchers design better studies and evaluate potential cancer therapies. Patients may benefit from improved understanding and treatment options as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals diagnosed with acute lymphoblastic leukemia or related cancers.
Not a fit: Patients with cancers unrelated to transcription elongation misregulation may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-targeted therapies for patients with acute lymphoblastic leukemia and other cancers.
How similar studies have performed: Other research has shown promise in using bioinformatics and computational approaches to advance cancer treatment, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Iwanaszko, Marta — Northwestern University at Chicago
- Study coordinator: Iwanaszko, Marta
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.